Comments
Loading...

AbbVie

ABBVNYSE
Logo brought to you by Benzinga Data
$203.87
2.371.18%
At close: -
$203.10
-0.77-0.38%
After Hours: 7:08 PM EDT
15 minutes delayed
Q3 2024 Earnings were released on Wed Oct 30th, before the market open
The most recent conference call was at 9:00 AM, 1 day ago Click to view past webcast
Aliada announced it will be acquired by AbbVie (ABBV) on Monday, October 28, 2024 for $1.4B paid in cash

AbbVie (NYSE:ABBV) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for AbbVie (ABBV)?

A

The most recent guidance for AbbVie (ABBV) was reported on October 30, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $2.94 to $2.98, compared to the estimated EPS of $2.95. Additionally, AbbVie forecasted revenue between $14.80B and $14.80B for the quarter.

Browse guidance and forecast on all stocks.

People Also Watch